Literature DB >> 2445084

Toxicology of FK-506 in the Lewis rat.

M A Nalesnik1, S Todo, N Murase, S Gryzan, P H Lee, L Makowka, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445084      PMCID: PMC2903834     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.

Authors:  T Ochiai; K Nakajima; M Nagata; T Suzuki; T Asano; T Uematsu; T Goto; S Hori; T Kenmochi; T Nakagoori
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

2.  Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats.

Authors:  H J Hahn; F Laube; S Lucke; I Klöting; K D Kohnert; R Warzock
Journal:  Transplantation       Date:  1986-01       Impact factor: 4.939

3.  Cyclosporin A and the thymus. Immunopathology.

Authors:  W E Beschorner; J D Namnoum; A D Hess; C A Shinn; G W Santos
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

  3 in total
  26 in total

1.  FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats.

Authors:  W J Tze; J Tai; S S Cheung; C Ricordi; N Murase; T E Starzl
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

2.  Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.

Authors:  D H Van Thiel; M Iqbal; A Jain; J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

3.  Pathologic observations in human allograft recipients treated with FK 506.

Authors:  A J Demetris; J J Fung; S Todo; B Banner; T Zerbe; G Sysyn; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

4.  Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation.

Authors:  Y Kang; M A Mazer; A M DeWolf; J J Fung; T Gasior; R Venkataramanan; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

5.  In vivo 31P nuclear magnetic resonance findings on heterotopically allografted hearts in rats treated with a novel immunosuppressant, FK506.

Authors:  S Suzuki; M Kanashiro; R Hayashi; T Kenmochi; T Fukuoka; H Amemiya
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

6.  FK 506 modulates D-galactosamine-induced hepatitis in rats.

Authors:  H Farghali; A Gasbarrini; A B Borle; M A Nalesnik; A Francavilla; S Fagiuoli; T E Starzl; D H Van Thiel
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

7.  Effect of FK 506 on glucose metabolism and insulin secretion in normal rats.

Authors:  W J Tze; J Tai; N Murase; A Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

8.  Effect of FK 506 chronic administration on bromosulphthalein hepatic excretion in rats.

Authors:  H Farghali; M Sakr; A Gasbarrini; R Venkataramanan; J Gavaler; T E Starzl; D H Van Thiel
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

9.  FK506: the promise and the paradox.

Authors:  D J White
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

10.  Inhibition by FK506 of established lesions of collagen-induced arthritis in rats.

Authors:  C Arita; T Hotokebuchi; H Miyahara; K Arai; Y Sugioka; N Kaibara
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.